Personalised regenerative medicine considers a patient’s individual health profile when assessing whether a regenerative approach may be appropriate. Healthcare professionals may review the condition, medical history, previous treatments, diagnostic findings, overall health, and treatment goals before discussing available options.

Key Takeaways

• Personalised regenerative medicine considers the individual patient, rather than relying only on the diagnosis.
• Treatment planning may take into account medical history, diagnostic findings, previous treatments, overall health, and recovery goals.
• Personalisation does not mean creating an entirely new therapy for every patient. It means adapting clinical decisions to the patient’s specific needs.
• The available scientific evidence and clinical guidelines should remain central to treatment decisions.
• Not every patient will be suitable for a regenerative approach, and conventional treatment or rehabilitation may sometimes remain the appropriate option.

Benefits of Personalised Regenerative Medicine Programs

When patients learn about personalised regenerative medicine, they often understand this as treatment is built from scratch for them. Although in regenerative medicine, it usually remains a practical approach, as patient often comes with different medical conditions, previous treatment histories, daily challenges, and expectations, even when they have the same condition.
This is where personalised regenerative medicine takes a different approach. Rather than looking at a diagnosis alone, healthcare providers can determine the wider medical situation while keeping evidence, safety, and realistic expectations at the centre of the decision. 

Knowing the reasons why treatment protocols are personalised can be helpful for patients when posing questions and setting realistic expectations.

What Does Personalised Regenerative Medicine Mean?

Personalised regenerative medicine does not necessarily mean creating a unique therapy for every patient. It means adapting clinical decision-making to the individual’s medical situation while keeping evidence, safety, and realistic expectations in view.

This process is based on certain fundamental principles:

• Health Assessment of Individuals: Each individual is assessed based on the person’s medical history, current health state, previous diagnostics and treatment measures, and not merely on the diagnosis.
• Clinical Decision-Making Based on Evidence: Treatment recommendations should be made based on current evidence and clinical guidelines, as well as an assessment of the case itself.
• Patient-Centered Approach: Patients are requested to provide information related to their symptoms, concerns, treatment objectives, and expectations so that an informed decision can be taken collectively.

Personalised regenerative medicine is not about developing a unique therapy for each patient. Rather, it involves developing personalised regimens for treatment based on the needs of every individual while ensuring safety and evidence-based medicine.

What Factors Influence a Personalised Treatment Plan?

A personalised treatment often looks beyond the diagnosis to understand the patient’s overall health, medical history, and individual goals. Healthcare professionals may consider several factors before deciding whether regenerative medicine is appropriate. 

Some of the important factors in developing a treatment plan include:

• Disease and Diagnosis: The type of disease, its severity, and the duration for which the symptoms have existed play an important role in determining the best treatment procedure to follow.
• Medical History: Surgical history, the other ailments that affect the individual, medications, previous treatments, allergies, among others, form part of the health profile of the patient.
• Diagnosis Findings: Patient clinical information may be obtained through imaging results and laboratory reports, among others.
• Lifestyle and Recovery Goals: Patient daily activity levels, occupation, physical demands, and personal recovery expectations may also be considered when discussing appropriate treatment options.
• Overall Health Status: Age, physical fitness, and pre-existing illnesses might affect the choice of treatment and also ensure that the treatment plan is customised to the patient’s needs.

Together, these factors help the healthcare professional assess which options may be appropriate for the individual rather than relying on the diagnosis alone.

How Can Personalisation Influence Treatment Planning?

Considering personalised care may help make regenerative medicine more closely aligned with patient medical needs and treatment goals. Rather than assuming that the same approach may work for every patient with a similar diagnosis, healthcare professionals trust patients’ individual clinical information when planning care. 

Some potential advantages include:

• Better Treatment Alignment: The proposed approach may reflect the patient’s condition, medical history, and recovery objectives.
• More Appropriate Clinical Decisions: Medical advice takes into account the whole clinical context rather than just the diagnosis.
• Realistic Treatment Expectation: The patient is aware of what the suggested treatment can accomplish, what is still unclear, and the limitations in terms of evidence.
• Patient Collaboration: Customised planning motivates the patient to be an active participant in the discussion of treatment possibilities.

Being patient-centred does not imply that any suggested treatment is going to yield better outcomes for everyone. The benefit of the method is in making the decision-making process more patient-specific and evidence-based.

Considering Risks and Treatment Suitability

With the help of personalisation, healthcare professionals now assess whether a regenerative medicine approach is appropriate for the patient. No treatment should be advised simply based on a similar patient condition. 

Before making a decision, clinicians may consider:

• Risks Involved: The health of the individual and medical situation play a role in determining any risks involved.
• Constraints of Treatment: Any information about the constraints and limitations that exist in using the method must be taken into account.
• Other Options: Conventional treatment or rehabilitation may remain appropriate in some cases.
• Patient Suitability: Not all patients qualify as candidates for all forms of regenerative medicine treatments.

This makes personalisation an important part of responsible treatment planning. The aim is not to fit every patient into a regenerative program, but to determine whether the approach makes sense for that particular clinical situation.

Cost and Practical Considerations in Personalised Regenerative Medicine

Cost considerations of regenerative medicine are to be taken into account along with medical appropriateness, treatment plan, and follow-up requirements. A lower-cost option is not necessarily more cost-effective if it is not clinically appropriate for the patient’s needs.

For patients considering a personalised program, it is useful to understand:

• Treatment Procedures: Patients need to know what the proposed program includes in terms of procedures and services.
• Medical Evaluation: The preliminary evaluation is used to determine whether or not regenerative medicine is right for the patient.
• Supporting Care: Rehabilitation or other supplementary care might also be a component of the entire program depending on clinical necessity.
• Follow-Up: The patient needs to know about any necessary follow-ups and tests in the future.

In case of international patients, it would be much better for them to see the whole picture of the care pathway and not just the cost of treatment.

Applications of Personalised Regenerative Medicine

Personalised regenerative medicine may be considered in several areas of healthcare, but the suitability of a regenerative approach depends on the individual condition and the evidence available for that specific application. 

Orthopaedic Conditions: In orthopaedic conditions, certain issues, including the location affected, extent of the condition, past treatments, mobility and rehabilitation goals, may affect the discussion of treatment options.

Neurological Conditions: In neurological conditions, factors such as diagnosis, disease progression, functional status, and previous medical treatment may influence whether a regenerative approach is considered.

Chronic and Degenerative Diseases: Patients suffering from chronic disease may need a wider evaluation of their health status and therapy experience before the option of regenerative medicine becomes applicable.

Other Emerging Applications: Further new uses for regenerative medicine are still being researched in other fields of medicine. The application of such methods will depend upon the scientific data and clinical factors.

Personalisation is necessary not because one method of regenerative therapy will be suitable for all conditions, but because of the different relevance of a method in each case.

Looking Ahead

Personalised regenerative medicine is not about being a promising avenue for every patient. It’s about looking at the patient’s condition thoroughly before deciding whether a regenerative approach is suitable. 

For patients considering regenerative medicine, the first step should be understanding whether the approach is suitable for their particular situation, rather than choosing a treatment simply because it is available.

Frequently Asked Questions

Q1. Does personalised regenerative medicine mean a treatment is created from scratch for each patient?

No. Personalised regenerative medicine commonly means combining clinical decision-making with the patient’s individual conditions rather than creating an entirely new therapy for every patient. 

Q2. Can a personalised regenerative medicine plan change over time?

Yes. A personalised care plan may be reviewed when symptoms, health status, clinical findings, or other relevant circumstances change. This allows healthcare professionals to reconsider whether the existing approach still reflects the patient’s current needs.

Q3. Is personalised regenerative medicine suitable for everyone?

No. Suitability depends on the individual medical situation and the evidence available for the proposed approach. In some cases, conventional treatment or rehabilitation may remain more appropriate.

Q4. Does personalisation guarantee better treatment outcomes?

No. Personalised planning is not a guarantee of a certain outcome. The goal of personalised planning is to improve the relevance of treatment decision-making, along with setting realistic expectations.

Q5. Can patients be involved in developing their regenerative medicine plan?

Yes. Patients can discuss their symptoms, concerns, treatment goals, and expectations with their healthcare team. This information can contribute to shared decision-making.

Q6. Are all personalised regenerative medicine approaches supported by the same level of evidence?

No. The scientific evidence may vary from one form of regenerative treatment to another and from one application of it in medicine to another. Patients need to think about the scientific evidence available for the particular method that is being talked about.

Reference Links

(1) Arjmand, B., Goodarzi, P., Mohamadi-Jahani, F., Falahzadeh, K., & Larijani, B. (2017). Personalized Regenerative Medicine. Acta Medica Iranica, 55(3), 144–149.

https://pubmed.ncbi.nlm.nih.gov/28282715/

(2) Hentze, H., Graichen, R., & Colman, A. (2007). Cell therapy and the safety of embryonic stem cell-derived grafts. Trends in Biotechnology, 25(1), 24–32.

https://pubmed.ncbi.nlm.nih.gov/17045790/

(3) Main, H., Munsie, M., & O’Connor, M. D. (2014). Managing the potential and pitfalls during clinical translation of emerging stem cell therapies. Clinical and Translational Medicine, 3, 10. DOI: 10.1186/2001-1326-3-10.

https://pubmed.ncbi.nlm.nih.gov/24949190/

(4) Heslop, J. A., Hammond, T. G., Santeramo, I., et al. (2015). Concise Review: Workshop Review: Understanding and Assessing the Risks of Stem Cell-Based Therapies. Stem Cells Translational Medicine, 4(4), 389–400. DOI: 10.5966/sctm.2014-0110.

https://pubmed.ncbi.nlm.nih.gov/25722427/

(5) Shapiro, S. A., Smith, C. G., Arthurs, J. R., & Master, Z. (2019). Preparing regenerative therapies for clinical application: proposals for responsible translation. Regenerative Medicine, 14(2), 77–84. DOI: 10.2217/rme-2018-0163.

https://pubmed.ncbi.nlm.nih.gov/30651044/

(6) Indian Council of Medical Research (ICMR) & Department of Biotechnology (DBT). (2017). National Guidelines for Stem Cell Research.

https://www.icmr.gov.in/icmrobject/custom_data/pdf/resource-guidelines/Guidelines_for_stem_cell_research_2017.pdf

Medical Disclaimer

This blog is for educational purposes only and is not a substitute for professional medical advice. Personalised regenerative medicine may have different levels of clinical evidence depending on the treatment and medical condition. Patients should consult a qualified healthcare professional before making any treatment decision.